TY  - GEN
AU  - Feld,Jordan J
AU  - Moreno,Christophe
AU  - Trinh,Roger
AU  - Tam,Edward
AU  - Bourgeois,Stefan
AU  - Horsmans,Yves
AU  - Elkhashab,Magdy
AU  - Bernstein,David E
AU  - Younes,Ziad
AU  - Reindollar,Robert W
AU  - Larsen,Lois
AU  - Fu,Bo
AU  - Howieson,Kevin
AU  - Polepally,Akshanth R
AU  - Pangerl,Andreas
AU  - Shulman,Nancy S
AU  - Poordad,Fred
TI  - Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks
SN  - 1600-0641
PY  - 2016///1213
KW  - 2-Naphthylamine
KW  - Adult
KW  - Aged
KW  - Anilides
KW  - administration & dosage
KW  - Antiviral Agents
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug Administration Schedule
KW  - Drug Combinations
KW  - Drug Resistance, Viral
KW  - Drug Therapy, Combination
KW  - methods
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - complications
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Liver Cirrhosis
KW  - Macrocyclic Compounds
KW  - Male
KW  - Middle Aged
KW  - Proline
KW  - analogs & derivatives
KW  - Ribavirin
KW  - Ritonavir
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Treatment Outcome
KW  - Uracil
KW  - Valine
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jhep.2015.10.005
ER  -